Cargando…
Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
QUESTIONS: In adult patients with inoperable locally advanced or metastatic soft-tissue sarcoma, do combination chemotherapy regimens containing ifosfamide have an advantage in terms of response rate, time to progression, or survival, as compared with similar regimens without ifosfamide when used as...
Autores principales: | Verma, S., Younus, J., Stys–Norman, D., Haynes, A.E, Blackstein, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948866/ https://www.ncbi.nlm.nih.gov/pubmed/17710206 |
Ejemplares similares
-
Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008) -
Guidelines for the Management of Soft Tissue Sarcomas
por: Grimer, Robert, et al.
Publicado: (2010) -
Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007) -
Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline
por: Verma, S., et al.
Publicado: (2008) -
(131)I–Tositumomab in lymphoma
por: Cheung, M.C., et al.
Publicado: (2009)